Coronary Drug-Eluting Stent-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Coronary Drug-Eluting Stent-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Coronary Drug-Eluting Stent industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Coronary Drug-Eluting Stent 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Coronary Drug-Eluting Stent worldwide and market share by regions, with company and product introduction, position in the Coronary Drug-Eluting Stent market
Market status and development trend of Coronary Drug-Eluting Stent by types and applications
Cost and profit status of Coronary Drug-Eluting Stent, and marketing status
Market growth drivers and challenges
The report segments the global Coronary Drug-Eluting Stent market as:
Global Coronary Drug-Eluting Stent Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Coronary Drug-Eluting Stent Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Durable Polymer Drug-eluting Stents
Bioabsorbable Polymer Drug-eluting Stent
Other
Global Coronary Drug-Eluting Stent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Coronary Heart Disease
Clinical
Global Coronary Drug-Eluting Stent Market: Manufacturers Segment Analysis (Company and Product introduction, Coronary Drug-Eluting Stent Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Cordis
Abbott
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Translumina
Vascular Concepts
JW Medical Systems
Kinhely
Lepu Medical
Medfavour Medical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Coronary Drug-Eluting Stent-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Coronary Drug-Eluting Stent industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Coronary Drug-Eluting Stent 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Coronary Drug-Eluting Stent worldwide and market share by regions, with company and product introduction, position in the Coronary Drug-Eluting Stent market
Market status and development trend of Coronary Drug-Eluting Stent by types and applications
Cost and profit status of Coronary Drug-Eluting Stent, and marketing status
Market growth drivers and challenges
The report segments the global Coronary Drug-Eluting Stent market as:
Global Coronary Drug-Eluting Stent Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Coronary Drug-Eluting Stent Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Durable Polymer Drug-eluting Stents
Bioabsorbable Polymer Drug-eluting Stent
Other
Global Coronary Drug-Eluting Stent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Coronary Heart Disease
Clinical
Global Coronary Drug-Eluting Stent Market: Manufacturers Segment Analysis (Company and Product introduction, Coronary Drug-Eluting Stent Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Cordis
Abbott
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Translumina
Vascular Concepts
JW Medical Systems
Kinhely
Lepu Medical
Medfavour Medical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CORONARY DRUG-ELUTING STENT
1.1 Definition of Coronary Drug-Eluting Stent in This Report
1.2 Commercial Types of Coronary Drug-Eluting Stent
1.2.1 Durable Polymer Drug-eluting Stents
1.2.2 Bioabsorbable Polymer Drug-eluting Stent
1.2.3 Other
1.3 Downstream Application of Coronary Drug-Eluting Stent
1.3.1 Coronary Heart Disease
1.3.2 Clinical
1.4 Development History of Coronary Drug-Eluting Stent
1.5 Market Status and Trend of Coronary Drug-Eluting Stent 2013-2023
1.5.1 Global Coronary Drug-Eluting Stent Market Status and Trend 2013-2023
1.5.2 Regional Coronary Drug-Eluting Stent Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Coronary Drug-Eluting Stent 2013-2017
2.2 Sales Market of Coronary Drug-Eluting Stent by Regions
2.2.1 Sales Volume of Coronary Drug-Eluting Stent by Regions
2.2.2 Sales Value of Coronary Drug-Eluting Stent by Regions
2.3 Production Market of Coronary Drug-Eluting Stent by Regions
2.4 Global Market Forecast of Coronary Drug-Eluting Stent 2018-2023
2.4.1 Global Market Forecast of Coronary Drug-Eluting Stent 2018-2023
2.4.2 Market Forecast of Coronary Drug-Eluting Stent by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Coronary Drug-Eluting Stent by Types
3.2 Sales Value of Coronary Drug-Eluting Stent by Types
3.3 Market Forecast of Coronary Drug-Eluting Stent by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Coronary Drug-Eluting Stent by Downstream Industry
4.2 Global Market Forecast of Coronary Drug-Eluting Stent by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Coronary Drug-Eluting Stent Market Status by Countries
5.1.1 North America Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
5.1.2 North America Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
5.1.3 United States Coronary Drug-Eluting Stent Market Status (2013-2017)
5.1.4 Canada Coronary Drug-Eluting Stent Market Status (2013-2017)
5.1.5 Mexico Coronary Drug-Eluting Stent Market Status (2013-2017)
5.2 North America Coronary Drug-Eluting Stent Market Status by Manufacturers
5.3 North America Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
5.3.1 North America Coronary Drug-Eluting Stent Sales by Type (2013-2017)
5.3.2 North America Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
5.4 North America Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Coronary Drug-Eluting Stent Market Status by Countries
6.1.1 Europe Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
6.1.2 Europe Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
6.1.3 Germany Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.4 UK Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.5 France Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.6 Italy Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.7 Russia Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.8 Spain Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.9 Benelux Coronary Drug-Eluting Stent Market Status (2013-2017)
6.2 Europe Coronary Drug-Eluting Stent Market Status by Manufacturers
6.3 Europe Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
6.3.1 Europe Coronary Drug-Eluting Stent Sales by Type (2013-2017)
6.3.2 Europe Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
6.4 Europe Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Coronary Drug-Eluting Stent Market Status by Countries
7.1.1 Asia Pacific Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
7.1.2 Asia Pacific Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
7.1.3 China Coronary Drug-Eluting Stent Market Status (2013-2017)
7.1.4 Japan Coronary Drug-Eluting Stent Market Status (2013-2017)
7.1.5 India Coronary Drug-Eluting Stent Market Status (2013-2017)
7.1.6 Southeast Asia Coronary Drug-Eluting Stent Market Status (2013-2017)
7.1.7 Australia Coronary Drug-Eluting Stent Market Status (2013-2017)
7.2 Asia Pacific Coronary Drug-Eluting Stent Market Status by Manufacturers
7.3 Asia Pacific Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
7.3.1 Asia Pacific Coronary Drug-Eluting Stent Sales by Type (2013-2017)
7.3.2 Asia Pacific Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
7.4 Asia Pacific Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Coronary Drug-Eluting Stent Market Status by Countries
8.1.1 Latin America Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
8.1.2 Latin America Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
8.1.3 Brazil Coronary Drug-Eluting Stent Market Status (2013-2017)
8.1.4 Argentina Coronary Drug-Eluting Stent Market Status (2013-2017)
8.1.5 Colombia Coronary Drug-Eluting Stent Market Status (2013-2017)
8.2 Latin America Coronary Drug-Eluting Stent Market Status by Manufacturers
8.3 Latin America Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
8.3.1 Latin America Coronary Drug-Eluting Stent Sales by Type (2013-2017)
8.3.2 Latin America Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
8.4 Latin America Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Coronary Drug-Eluting Stent Market Status by Countries
9.1.1 Middle East and Africa Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
9.1.3 Middle East Coronary Drug-Eluting Stent Market Status (2013-2017)
9.1.4 Africa Coronary Drug-Eluting Stent Market Status (2013-2017)
9.2 Middle East and Africa Coronary Drug-Eluting Stent Market Status by Manufacturers
9.3 Middle East and Africa Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Coronary Drug-Eluting Stent Sales by Type (2013-2017)
9.3.2 Middle East and Africa Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
9.4 Middle East and Africa Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF CORONARY DRUG-ELUTING STENT
10.1 Global Economy Situation and Trend Overview
10.2 Coronary Drug-Eluting Stent Downstream Industry Situation and Trend Overview
CHAPTER 11 CORONARY DRUG-ELUTING STENT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Coronary Drug-Eluting Stent by Major Manufacturers
11.2 Production Value of Coronary Drug-Eluting Stent by Major Manufacturers
11.3 Basic Information of Coronary Drug-Eluting Stent by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Coronary Drug-Eluting Stent Major Manufacturer
11.3.2 Employees and Revenue Level of Coronary Drug-Eluting Stent Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 CORONARY DRUG-ELUTING STENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Boston Scientific
12.1.1 Company profile
12.1.2 Representative Coronary Drug-Eluting Stent Product
12.1.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Boston Scientific
12.2 Cordis
12.2.1 Company profile
12.2.2 Representative Coronary Drug-Eluting Stent Product
12.2.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Cordis
12.3 Abbott
12.3.1 Company profile
12.3.2 Representative Coronary Drug-Eluting Stent Product
12.3.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Abbott
12.4 Advantec Vascular
12.4.1 Company profile
12.4.2 Representative Coronary Drug-Eluting Stent Product
12.4.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Advantec Vascular
12.5 B.Braun Melsengen AG
12.5.1 Company profile
12.5.2 Representative Coronary Drug-Eluting Stent Product
12.5.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of B.Braun Melsengen AG
12.6 Biosensors
12.6.1 Company profile
12.6.2 Representative Coronary Drug-Eluting Stent Product
12.6.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Biosensors
12.7 Biotronik
12.7.1 Company profile
12.7.2 Representative Coronary Drug-Eluting Stent Product
12.7.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Biotronik
12.8 Blue Medical
12.8.1 Company profile
12.8.2 Representative Coronary Drug-Eluting Stent Product
12.8.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Blue Medical
12.9 DISA Vascular
12.9.1 Company profile
12.9.2 Representative Coronary Drug-Eluting Stent Product
12.9.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of DISA Vascular
12.10 Essen
12.10.1 Company profile
12.10.2 Representative Coronary Drug-Eluting Stent Product
12.10.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Essen
12.11 Medtronic Vascular
12.11.1 Company profile
12.11.2 Representative Coronary Drug-Eluting Stent Product
12.11.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Medtronic Vascular
12.12 MicroPort Medical
12.12.1 Company profile
12.12.2 Representative Coronary Drug-Eluting Stent Product
12.12.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of MicroPort Medical
12.13 MIV Therapeutics
12.13.1 Company profile
12.13.2 Representative Coronary Drug-Eluting Stent Product
12.13.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of MIV Therapeutics
12.14 Orbusneich
12.14.1 Company profile
12.14.2 Representative Coronary Drug-Eluting Stent Product
12.14.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Orbusneich
12.15 Promed Medical
12.15.1 Company profile
12.15.2 Representative Coronary Drug-Eluting Stent Product
12.15.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Promed Medical
12.16 Relisys Medical
12.17 Reva Medical
12.18 Sahajanand
12.19 Sino Medical
12.20 Sorin
12.21 Terumo Medical
12.22 Translumina
12.23 Vascular Concepts
12.24 JW Medical Systems
12.25 Kinhely
12.26 Lepu Medical
12.27 Medfavour Medical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CORONARY DRUG-ELUTING STENT
13.1 Industry Chain of Coronary Drug-Eluting Stent
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF CORONARY DRUG-ELUTING STENT
14.1 Cost Structure Analysis of Coronary Drug-Eluting Stent
14.2 Raw Materials Cost Analysis of Coronary Drug-Eluting Stent
14.3 Labor Cost Analysis of Coronary Drug-Eluting Stent
14.4 Manufacturing Expenses Analysis of Coronary Drug-Eluting Stent
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Coronary Drug-Eluting Stent in This Report
1.2 Commercial Types of Coronary Drug-Eluting Stent
1.2.1 Durable Polymer Drug-eluting Stents
1.2.2 Bioabsorbable Polymer Drug-eluting Stent
1.2.3 Other
1.3 Downstream Application of Coronary Drug-Eluting Stent
1.3.1 Coronary Heart Disease
1.3.2 Clinical
1.4 Development History of Coronary Drug-Eluting Stent
1.5 Market Status and Trend of Coronary Drug-Eluting Stent 2013-2023
1.5.1 Global Coronary Drug-Eluting Stent Market Status and Trend 2013-2023
1.5.2 Regional Coronary Drug-Eluting Stent Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Coronary Drug-Eluting Stent 2013-2017
2.2 Sales Market of Coronary Drug-Eluting Stent by Regions
2.2.1 Sales Volume of Coronary Drug-Eluting Stent by Regions
2.2.2 Sales Value of Coronary Drug-Eluting Stent by Regions
2.3 Production Market of Coronary Drug-Eluting Stent by Regions
2.4 Global Market Forecast of Coronary Drug-Eluting Stent 2018-2023
2.4.1 Global Market Forecast of Coronary Drug-Eluting Stent 2018-2023
2.4.2 Market Forecast of Coronary Drug-Eluting Stent by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Coronary Drug-Eluting Stent by Types
3.2 Sales Value of Coronary Drug-Eluting Stent by Types
3.3 Market Forecast of Coronary Drug-Eluting Stent by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Coronary Drug-Eluting Stent by Downstream Industry
4.2 Global Market Forecast of Coronary Drug-Eluting Stent by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Coronary Drug-Eluting Stent Market Status by Countries
5.1.1 North America Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
5.1.2 North America Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
5.1.3 United States Coronary Drug-Eluting Stent Market Status (2013-2017)
5.1.4 Canada Coronary Drug-Eluting Stent Market Status (2013-2017)
5.1.5 Mexico Coronary Drug-Eluting Stent Market Status (2013-2017)
5.2 North America Coronary Drug-Eluting Stent Market Status by Manufacturers
5.3 North America Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
5.3.1 North America Coronary Drug-Eluting Stent Sales by Type (2013-2017)
5.3.2 North America Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
5.4 North America Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Coronary Drug-Eluting Stent Market Status by Countries
6.1.1 Europe Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
6.1.2 Europe Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
6.1.3 Germany Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.4 UK Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.5 France Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.6 Italy Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.7 Russia Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.8 Spain Coronary Drug-Eluting Stent Market Status (2013-2017)
6.1.9 Benelux Coronary Drug-Eluting Stent Market Status (2013-2017)
6.2 Europe Coronary Drug-Eluting Stent Market Status by Manufacturers
6.3 Europe Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
6.3.1 Europe Coronary Drug-Eluting Stent Sales by Type (2013-2017)
6.3.2 Europe Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
6.4 Europe Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Coronary Drug-Eluting Stent Market Status by Countries
7.1.1 Asia Pacific Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
7.1.2 Asia Pacific Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
7.1.3 China Coronary Drug-Eluting Stent Market Status (2013-2017)
7.1.4 Japan Coronary Drug-Eluting Stent Market Status (2013-2017)
7.1.5 India Coronary Drug-Eluting Stent Market Status (2013-2017)
7.1.6 Southeast Asia Coronary Drug-Eluting Stent Market Status (2013-2017)
7.1.7 Australia Coronary Drug-Eluting Stent Market Status (2013-2017)
7.2 Asia Pacific Coronary Drug-Eluting Stent Market Status by Manufacturers
7.3 Asia Pacific Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
7.3.1 Asia Pacific Coronary Drug-Eluting Stent Sales by Type (2013-2017)
7.3.2 Asia Pacific Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
7.4 Asia Pacific Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Coronary Drug-Eluting Stent Market Status by Countries
8.1.1 Latin America Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
8.1.2 Latin America Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
8.1.3 Brazil Coronary Drug-Eluting Stent Market Status (2013-2017)
8.1.4 Argentina Coronary Drug-Eluting Stent Market Status (2013-2017)
8.1.5 Colombia Coronary Drug-Eluting Stent Market Status (2013-2017)
8.2 Latin America Coronary Drug-Eluting Stent Market Status by Manufacturers
8.3 Latin America Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
8.3.1 Latin America Coronary Drug-Eluting Stent Sales by Type (2013-2017)
8.3.2 Latin America Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
8.4 Latin America Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Coronary Drug-Eluting Stent Market Status by Countries
9.1.1 Middle East and Africa Coronary Drug-Eluting Stent Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Coronary Drug-Eluting Stent Revenue by Countries (2013-2017)
9.1.3 Middle East Coronary Drug-Eluting Stent Market Status (2013-2017)
9.1.4 Africa Coronary Drug-Eluting Stent Market Status (2013-2017)
9.2 Middle East and Africa Coronary Drug-Eluting Stent Market Status by Manufacturers
9.3 Middle East and Africa Coronary Drug-Eluting Stent Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Coronary Drug-Eluting Stent Sales by Type (2013-2017)
9.3.2 Middle East and Africa Coronary Drug-Eluting Stent Revenue by Type (2013-2017)
9.4 Middle East and Africa Coronary Drug-Eluting Stent Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF CORONARY DRUG-ELUTING STENT
10.1 Global Economy Situation and Trend Overview
10.2 Coronary Drug-Eluting Stent Downstream Industry Situation and Trend Overview
CHAPTER 11 CORONARY DRUG-ELUTING STENT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Coronary Drug-Eluting Stent by Major Manufacturers
11.2 Production Value of Coronary Drug-Eluting Stent by Major Manufacturers
11.3 Basic Information of Coronary Drug-Eluting Stent by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Coronary Drug-Eluting Stent Major Manufacturer
11.3.2 Employees and Revenue Level of Coronary Drug-Eluting Stent Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 CORONARY DRUG-ELUTING STENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Boston Scientific
12.1.1 Company profile
12.1.2 Representative Coronary Drug-Eluting Stent Product
12.1.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Boston Scientific
12.2 Cordis
12.2.1 Company profile
12.2.2 Representative Coronary Drug-Eluting Stent Product
12.2.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Cordis
12.3 Abbott
12.3.1 Company profile
12.3.2 Representative Coronary Drug-Eluting Stent Product
12.3.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Abbott
12.4 Advantec Vascular
12.4.1 Company profile
12.4.2 Representative Coronary Drug-Eluting Stent Product
12.4.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Advantec Vascular
12.5 B.Braun Melsengen AG
12.5.1 Company profile
12.5.2 Representative Coronary Drug-Eluting Stent Product
12.5.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of B.Braun Melsengen AG
12.6 Biosensors
12.6.1 Company profile
12.6.2 Representative Coronary Drug-Eluting Stent Product
12.6.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Biosensors
12.7 Biotronik
12.7.1 Company profile
12.7.2 Representative Coronary Drug-Eluting Stent Product
12.7.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Biotronik
12.8 Blue Medical
12.8.1 Company profile
12.8.2 Representative Coronary Drug-Eluting Stent Product
12.8.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Blue Medical
12.9 DISA Vascular
12.9.1 Company profile
12.9.2 Representative Coronary Drug-Eluting Stent Product
12.9.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of DISA Vascular
12.10 Essen
12.10.1 Company profile
12.10.2 Representative Coronary Drug-Eluting Stent Product
12.10.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Essen
12.11 Medtronic Vascular
12.11.1 Company profile
12.11.2 Representative Coronary Drug-Eluting Stent Product
12.11.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Medtronic Vascular
12.12 MicroPort Medical
12.12.1 Company profile
12.12.2 Representative Coronary Drug-Eluting Stent Product
12.12.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of MicroPort Medical
12.13 MIV Therapeutics
12.13.1 Company profile
12.13.2 Representative Coronary Drug-Eluting Stent Product
12.13.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of MIV Therapeutics
12.14 Orbusneich
12.14.1 Company profile
12.14.2 Representative Coronary Drug-Eluting Stent Product
12.14.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Orbusneich
12.15 Promed Medical
12.15.1 Company profile
12.15.2 Representative Coronary Drug-Eluting Stent Product
12.15.3 Coronary Drug-Eluting Stent Sales, Revenue, Price and Gross Margin of Promed Medical
12.16 Relisys Medical
12.17 Reva Medical
12.18 Sahajanand
12.19 Sino Medical
12.20 Sorin
12.21 Terumo Medical
12.22 Translumina
12.23 Vascular Concepts
12.24 JW Medical Systems
12.25 Kinhely
12.26 Lepu Medical
12.27 Medfavour Medical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CORONARY DRUG-ELUTING STENT
13.1 Industry Chain of Coronary Drug-Eluting Stent
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF CORONARY DRUG-ELUTING STENT
14.1 Cost Structure Analysis of Coronary Drug-Eluting Stent
14.2 Raw Materials Cost Analysis of Coronary Drug-Eluting Stent
14.3 Labor Cost Analysis of Coronary Drug-Eluting Stent
14.4 Manufacturing Expenses Analysis of Coronary Drug-Eluting Stent
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
